CanniMed

Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2020 Investor Conference Call and Related Year End Informational Filings

Retrieved on: 
Monday, September 14, 2020

These material weaknesses are a result of a number of significant changes to the Company during the fiscal year, including the Business Transformation Plan announced in February 2020.

Key Points: 
  • These material weaknesses are a result of a number of significant changes to the Company during the fiscal year, including the Business Transformation Plan announced in February 2020.
  • Aurora is a global leader in the cannabis industry serving both the medical and consumer markets.
  • Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives.
  • The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva.

Aurora Cannabis Appoints Miguel Martin as CEO

Retrieved on: 
Tuesday, September 8, 2020

EDMONTON, AB, Sept.8, 2020 /PRNewswire/ - Aurora Cannabis Inc. (the "Company " or "Aurora") (NYSE: ACB)(TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that Miguel Martin has been appointed Chief Executive Officer, effective immediately.

Key Points: 
  • EDMONTON, AB, Sept.8, 2020 /PRNewswire/ - Aurora Cannabis Inc. (the "Company " or "Aurora") (NYSE: ACB)(TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that Miguel Martin has been appointed Chief Executive Officer, effective immediately.
  • "I am excited to step into the role of CEO at this inflection point in Aurora's business," said Miguel Martin.
  • Mr. Martin is a 25-year consumer packaged goods industry veteran who joined Aurora from Reliva where he served as Chief Executive Officer.
  • The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD.

Aurora Cannabis Announces Retirement of Terry Booth from Board of Directors

Retrieved on: 
Monday, June 29, 2020

Mr. Booth was the Chief Executive Officer of Aurora from December 2014 through February 2020 and served on Aurora's Board of Directors since December 2014.

Key Points: 
  • Mr. Booth was the Chief Executive Officer of Aurora from December 2014 through February 2020 and served on Aurora's Board of Directors since December 2014.
  • "As one of the original cannabis visionaries, Terry leaves an enviable legacy in the form of Aurora Cannabis.
  • Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives.
  • The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Reliva CBD and ROAR Sports.

Aurora Cannabis Announces Retirement of Co-Founder and President Steve Dobler

Retrieved on: 
Tuesday, June 16, 2020

Mr. Dobler has been the President of Aurora and a member of Aurora's Board of Directors since December 2014.

Key Points: 
  • Mr. Dobler has been the President of Aurora and a member of Aurora's Board of Directors since December 2014.
  • With the retirement of Mr. Dobler, the board currently has nine directors, seven of whom remain independent.
  • Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives.
  • The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and ROAR Sports.

Aurora Cannabis to Host Third Quarter 2020 Investor Conference Call

Retrieved on: 
Friday, May 1, 2020

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets.

Key Points: 
  • Aurora is a global leader in the cannabis industry serving both the medical and consumer markets.
  • Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives.
  • The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and ROAR Sports.
  • This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements").

Worldwide Medical Cannabis Market 2019-2024: Projected to Exhibit a CAGR of 16.82%, with Cannabis Indica Witnessing Noteworthy Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 18, 2019

The report analyzes the Global Medical Cannabis Market for the historical period of 2014-2018 and the forecast period of 2019-2024.

Key Points: 
  • The report analyzes the Global Medical Cannabis Market for the historical period of 2014-2018 and the forecast period of 2019-2024.
  • According to the report, the market is projected to display a robust growth represented by a CAGR of 16.82% during 2019-2024.
  • Amongst the regions, North America accounts for the largest regional share in the global medical cannabis market in 2019.
  • Global Medical Cannabis Market (Actual Period: 2014-2018, Forecast Period: 2019-2024
    Global Medical Cannabis Market - Size, Growth, Forecast
    By Production Type (Cannabis Indica, Cannabis Sativa, Others)
    Regional Markets - North America, Europe, APAC and Rest of the World (Actual Period: 2014-2018, Forecast Period: 2019-2024)
    Regional Medical Cannabis Market - Size, Growth, Forecast
    By Production Type (Cannabis Indica, Cannabis Sativa, Others)
    By Production Type (Cannabis Indica, Cannabis Sativa, Others)
    Company Analysis - Scotts Miracle-Gro Co, Canopy Growth Corp(Canada), GW Pharmaceuticals PLC, Aurora Cannabis Inc (Canada), Aphria Inc (Canada), MedReLeaf Corp, Medical Marijuana, INC, Insys Therapeutics Inc, CanniMed Therapeutics Inc, Cara Therapeutics Inc.

Global Medical Cannabis Market is projected to display a robust growth represented by a CAGR of 16.82% during 2019 - 2024

Retrieved on: 
Wednesday, April 17, 2019

The report analyzes the Global Medical Cannabis Market By Product Type (Cannabis Indica, Cannabis Sativa, Others), By Application (Chronic Pain, Mental Disorders, Cancer, Others) and By Consumption Pattern (Flowers, Concentrates, Edibles, Others).

Key Points: 
  • The report analyzes the Global Medical Cannabis Market By Product Type (Cannabis Indica, Cannabis Sativa, Others), By Application (Chronic Pain, Mental Disorders, Cancer, Others) and By Consumption Pattern (Flowers, Concentrates, Edibles, Others).
  • Amongst the regions, North America accounts for the largest regional share in the global medical cannabis market in 2019.
  • Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Medical Cannabis market.
  • Global Medical Cannabis Market (Actual Period: 2014-2018, Forecast Period: 2019-2024
    Global Medical Cannabis Market Size, Growth, Forecast
    By Production Type (Cannabis Indica, Cannabis Sativa, Others)
    Regional Markets North America, Europe, APAC and Rest of the World (Actual Period: 2014-2018, Forecast Period: 2019-2024)
    Regional Medical Cannabis Market Size, Growth, Forecast
    By Production Type (Cannabis Indica, Cannabis Sativa, Others)
    By Production Type (Cannabis Indica, Cannabis Sativa, Others)
    Company Analysis Scotts Miracle-Gro Co, Canopy Growth Corp(Canada), GW Pharmaceuticals PLC, Aurora Cannabis Inc (Canada), Aphria Inc (Canada), MedReLeaf Corp, Medical Marijuana, INC, Insys Therapeutics Inc, CanniMed Therapeutics Inc, Cara Therapeutics Inc.